Founded in 2013 by Dr. Elina Berglund Scherwitzl and Dr. Raoul Scherwitzl, Natural Cycles is a leading women’s digital health company that developed the world’s first birth control app.
As a medical device, the NC° app is cleared by the FDA in the United States and certified to be used as a contraceptive in the UK, Canada, Australia, Singapore, and South Korea.
The NC° app is powered by an algorithm and artificial intelligence that use body temperature to determine each user’s daily fertility status.
Users can manually take their body temperature with a thermometer or sync overnight temperature trend data from an Oura Ring or Apple Watch when they wake up.
Company : Natural Cycles
Investment type : Growth Equity
Investment date : May 2024
Location : Stockholm, Sweden
Website : Natural Cycles
Youtube : Youtube page
“Our mission at Lauxera is to partner with ambitious entrepreneurs transforming the future of medicine with unique technology. The visionary Natural Cycles team has built an exceptional company delivering profitable growth supported by unique clinical and regulatory business moats. We are delighted to partner with Elina, Raoul and their team to offer women an alternative to traditional approaches without the side effects and compromises.”
Samuel Levy, Associé-Fondateur à Lauxera